Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00483444 · ClinicalTrials.gov registry record · NA

Telephone Follow-Up on Outcome After Mild Traumatic Brain Injury

A NA study of Brain Concussion, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
366
Enrollment target
1
Study location

NCT00483444: Completed NA study of Brain Concussion, sponsored by University of Washington.

NCT00483444 is a NA study of Brain Concussion that has completed, run by University of Washington. The registered enrollment target is 366 participants, above the 276-participant average among 17 other Brain Concussion trials with a reported enrollment target (33% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00483444, a NA study of Brain Concussion, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
366 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see whether providing education and counseling after a mild traumatic brain injury will help in preventing symptoms from becoming chronic over the first six months after injury.

Conditions Studied

Interventions

  • BEHAVIORAL Scheduled telephone follow-up

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 366 participants
Start Date 2003-10
Est. Completion 2006-05
Phase NA
University of Washington

1,048 total trials

What the finished NCT00483444 record still lists

NCT00483444 is an interventional study that assigns participants to a tested intervention. The registered 366 participants enrollment target is mid-sized for trials with a published cap, above the 276-participant average among 17 other Brain Concussion trials with a reported enrollment target (33% higher).

The record links to 1 condition, with Brain Concussion appearing as the primary indexed condition, and to 1 intervention - of which Scheduled telephone follow-up is the first listed.

NCT00483444 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT00483444 about?

NCT00483444 is a clinical study titled "Telephone Follow-Up on Outcome After Mild Traumatic Brain Injury". The purpose of this study is to see whether providing education and counseling after a mild traumatic brain injury will help in preventing symptoms from becoming chronic over the first six months after injury.

What is the current status of trial NCT00483444?

This trial is currently completed. It is a NA study. The enrollment target is 366 participants. The study started on 2003-10. Estimated completion is 2006-05.

What conditions does trial NCT00483444 study?

This clinical trial studies the following conditions: Brain Concussion.

What interventions are being tested in trial NCT00483444?

The interventions under investigation include: Scheduled telephone follow-up (BEHAVIORAL).

Who is sponsoring clinical trial NCT00483444?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00483444 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Brain Concussion

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00483444's enrollment target sits among peer trials

366 3rd of 17 higher than 15 of 17 other Brain Concussion trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Brain Concussion trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05083481 · 366 participants · Phase 1

    A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

  • NCT05429632 · 366 participants · Phase 3

    Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

  • NCT06979453 · 366 participants · Phase 3

    A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

  • NCT04049604 · 365 participants · NA

    IDENTIFY Study: Natural History of Maternal Neoplasia

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00483444, the US trial registry maintained by the National Library of Medicine. NCT00483444 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.